美金刚治疗认知障碍的研究进展

被引:4
作者
王天俊
王建华
吕佩源
机构
[1] 河北省人民医院神经内科
关键词
阿尔茨海默病; 痴呆; 认知障碍; 美金刚;
D O I
暂无
中图分类号
R749.1 [脑器质性精神障碍];
学科分类号
摘要
<正>美金刚于1968年被发现,在化学分类上属于金刚烷胺类,目前在临床上广泛用于中重度阿尔茨海默病(Alzheimer's disease,AD)的治疗。该药除了能促进多巴胺能神经末梢释放多巴胺外,还具有非竞争性N-甲基-D-天冬氨酸(NMDA)受体拮抗剂的作用。目前美金刚(易倍申,Ebixa)也被用于其他类
引用
收藏
页码:2191 / 2194
页数:4
相关论文
共 25 条
[1]  
Clinical rehabilitative effect of memantine on cognitive and motor disorders in patients with Parkinson’’s disease. Li W,Zhao JH,Sun SG,et al. Chinese Medical Journal . 2011
[2]  
The role of memantine in the treatment of psychiatric disorders other than the dementias:a review of current preclinical and clinical evidence. Sani G,Serra G,Kotzalidis GD,et al. CNS Drugs . 2012
[3]  
Memantine in severe dementia: results of the 9M Best Study (Benefit and efficacy in severely demented patients during treatment with memantine). Winblad B,Poritis N. International Journal of Geriatric Psychiatry . 1999
[4]  
Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease. OL Lopez,JT Becker,AS Wahed. Journal of Neurology Neurosurgery and Psychiatry . 2009
[5]  
Memantine treatment in patients with mild to moderate Alzheimer’’’’s disease:results of a randomised,double-blind,placebo-controlled 6-month study. Bakchine S,Lo H. Journal of Alzheimer s Disease . 2008
[6]  
Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. Tariot PN,Farlow MR,Grossberg GT,Graham SM,McDonald S,Gergel I. Journal of the American Medical Association, The . 2004
[7]  
Memantine in moderate-to-severe Alzheimer’s disease. Reisberg B,Doody R,Stoffler A,et al. New England Journal of Medicine, The . 2003
[8]  
Quality of life and the effect of memantine in dementia with lewy bodies and Parkinson’s disease dementia. V Larsson,K Engedal,D Aarsland,C Wattmo,L Minthon,E Londos. Dementia and Geriatric Cognitive Disorders . 2011
[9]  
Memantine therapy of behavioral symptoms in community-dwelling pa-tients with moderate to severe Alzheimer‘s disease. Grossberg GT,Pejovic V,Miller MLet al. De-ment Geriatr Cogn Disord . 2009
[10]  
Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300). Orgogozo JM,Rigaud AS,Stoffler A,et al. Stroke . 2002